EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

A Review of Papillary Renal Cell Carcinoma and MET Inhibitors

Katherine Emilie Rhoades Smith, Mehmet Asim Bilen

Kidney Cancer · 01.11.2019 · 3 (3) · 151-161

DOI: 10.3233/kca-190058 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Kidney Cancer, online erschienen am 17.08.2019. Verfasst von Katherine Emilie Rhoades Smith und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Papillary renal cell carcinoma (PRCC) is a subtype of renal cell carcinoma (RCC) accounting for approximately 15–20% of cases and further divided into Type 1 and Type 2. Type 1 PRCC tends to have more alterations in the MET tyrosine kinase receptor than Type 2 PRCC. Treatment for RCC patients is based on studies with minimal participation from patients with PRCC; consequently, conventional therapies tend to be less effective for RCC patients with a subtype other than ccRCC (non-ccRCC). Since MET is a known alteration in PRCC, it is potential target for directed therapy. There have been many attempts to develop MET inhibitors for use in solid tumors including PRCC. The following review will discuss the current research regarding MET-targeted therapy, MET inhibitors in clinical trials, and future directions for MET inhibitors in PRCC.

Schlagwörter

Stichwörter der Autor:innen

METPapillary renal carcinomaimmune-checkpoint inhibitorkidney cancermolecularly targeted therapiesnon-clear cell renal cell carcinomarenal cell cancer

Autor:innen und Institutionen

  • Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Zitieren

APA

Rhoades Smith, K. E., & Bilen, M. A. (2019). A Review of Papillary Renal Cell Carcinoma and MET Inhibitors. Kidney Cancer, 3(3), 151-161. https://doi.org/10.3233/kca-190058

Vancouver

Rhoades Smith KE, Bilen MA. A Review of Papillary Renal Cell Carcinoma and MET Inhibitors. Kidney Cancer. 2019;3(3):151-161. doi:10.3233/kca-190058

BibTeX
@article{RhoadesSmith2019,
  author = {Rhoades Smith, Katherine Emilie and Bilen, Mehmet Asim},
  title = {A Review of Papillary Renal Cell Carcinoma and MET Inhibitors},
  journal = {Kidney Cancer},
  year = {2019},
  volume = {3},
  number = {3},
  pages = {151--161},
  doi = {10.3233/kca-190058}
}
Kostenlos starten →